1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Respiratory Therapy News FEBRUARY 2015

Respiratory Therapy News FEBRUARY 2015

  • February 2015
  • -
  • Espicom Business Intelligence
  • -
  • 13 pages

Industry Trend Analysis - AstraZeneca Further Bolsters Respiratory Portfolio
Industry Trend Analysis - IPF ODD Status Advances PBI-4050 Toward Success
Industry Brief - GSK Launches Two Products In US For Asthma/COPD
Industry Brief - CHMP Adopts Positive Opinion On Abraxane For First-Line NSCLC
Industry Brief - Enrolment Begins In Global Tiotropium+Olodaterol Respimat COPD Study
Industry Brief - OSE Pharma/Simbec-Orion Begin Tedopi Phase III Trial In HLA-A2+ NSCLC
Industry Brief - AstraZeneca Gains Planning Consent For Global R&D Centre/Corporate HQ In Cambridge
Industry Brief - Dosing Begins In OncoMed's Demcizumab Phase II Trial For NSCLC
Industry Trend Analysis - Synta's Workforce Slash In Line With Focus On Gaining Ganetespib Approval
Industry Brief - Theravance/Mylan Enter Collaboration For COPD
Industry Brief - FDA Grants ODD To Ignyta's Entrectinib For Molecularly Defined Subsets Of NSCLC
Industry Brief - FDA Grants Breakthrough Therapy Designation To Genentech's Anti-PDL1 Immunotherapy
Industry Trend Analysis - OncoMed's Latest ODD Highlights Anti-CSC Potential
Industry Brief - Peregrine's PS-Targeting Antibodies Significantly Enhance Antitumour Activity
Industry Brief - FDA Approves Phase II Trial Protocol For MediciNova's MN-001 In IPF
Industry Trend Analysis - Patent Ruling Edges Pulmicort Respules Toward Lifecycle End
Industry Trend Analysis - Motesanib Likely To Be Shelved After Another Phase III Failure
Industry Brief - Lupin And Celon Enter Fluticasone+Salmeterol Agreement

Table Of Contents

Respiratory Therapy News FEBRUARY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.